Category: Biosimilars
Biosimilars market research reports by Stratistics Market Research Consulting
-
Erythropoietin Drugs Market Forecasts to 2030 – Global Analysis By Type (Biosimilars and Biologics), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Other Products), Distribution Channel, Application, End User and By Geography
Erythropoietin Drugs Market Forecasts to 2030 – Global Analysis By Type (Biosimilars and Biologics), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Other Products), Distribution Channel, Application, End User and By Geography According to Stratistics MRC, the Global Erythropoietin Drugs M ... Read More
-
Generic Drug Market Forecasts to 2030 – Global Analysis By Product Type (Super Generics, Biosimilar Generics and Simple Generic), Route of Administration, Drug Class, Indication, Application, Distribution Channel, End User and By Geography
Generic Drug Market Forecasts to 2030 – Global Analysis By Product Type (Super Generics, Biosimilar Generics and Simple Generic), Route of Administration, Drug Class, Indication, Application, Distribution Channel, End User and By Geography According to Stratistics MRC, the Global Generic Drug Market ... Read More
-
Biopharmaceutical CMO Market Forecasts to 2030 – Global Analysis By Product (Biologics, Biosimilars and Other Products), Source, Service and By Geography
Biopharmaceutical CMO Market Forecasts to 2030 – Global Analysis By Product (Biologics, Biosimilars and Other Products), Source, Service and By Geography According to Stratistics MRC, the Global Biopharmaceutical CMO Market is accounted for $15.18 billion in 2023 and is expected to reach $39.41 bill ... Read More
-
Biosimilars Market Forecasts to 2030 – Global Analysis By Drug Class (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins and Other Drug Classes), Manufacturing Type (In-house Manufacturing and Contract Manufacturing), Technology (Mass Spectroscopy, Chromatography, Monoclonal Antibody Technology and Other Technologies), Application, End User and By Geography
Biosimilars Market Forecasts to 2030 – Global Analysis By Drug Class (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins and Other Drug Classes), Manufacturing Type (In-house Manufacturing and Contract Manufacturing), Technology (Mass Spectroscopy, Chromatography, Monoclonal An ... Read More
Research Assistance
